Ryzodeg FlexTouch
Ryzodeg FlexTouch is a medicine authorised by Swissmedic under authorisation number 62648. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 September 2013 and the authorisation is valid without a time limit. ATC code A10AD06 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 62648 |
|---|---|
| Name | Ryzodeg FlexTouch |
| Full name | Ryzodeg FlexTouch , Injektionslösung |
| Authorisation holder | Novo Nordisk Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10AD06 |
| First authorisation | 12 September 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ryzodeg FlexTouch , Injektionslösung | B | 12 September 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 x 3 | ml | A10AD06 | 07.06.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ryzodeg FlexTouch authorised in Switzerland?
Yes. Ryzodeg FlexTouch is authorised by Swissmedic under authorisation number 62648, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ryzodeg FlexTouch have?
Ryzodeg FlexTouch is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ryzodeg FlexTouch?
The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.